The Week Ahead: Fed...
Health Care: Drugs
AspenBio Pharma Inc. (APPY: NASDAQ)
$0.49 0.01 | 2.51%
06/04/12 - 10:18 AM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 2.97M | 8.91M | 13.37M | 11.82M |
| Receivables | 35.02K | 73.18K | 47.96K | 63.19K |
| Inventories | 0.00 | 17.13K | 339.55K | 572.29K |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 4.32M | 12.31M | 14.43M | 18.87M |
| Property, Plant & Equipment, Gross | 5.52M | 5.52M | 5.33M | 5.10M |
| Accumulated Depreciation & Depletion | 2.73M | 2.41M | 2.02M | 1.68M |
| Property, Plant & Equipment, Net | 2.80M | 3.11M | 3.31M | 3.42M |
| Intangibles | 1.21M | 1.34M | 1.23M | 1.49M |
| Other Non-Current Assets | 9.66K | 15.37K | 21.08K | 26.79K |
| Total Non-Current Assets | 4.41M | 4.85M | 4.95M | 5.32M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 8.73M | 17.16M | 19.38M | 24.19M |
| Accounts Payable | 581.71K | 1.13M | 1.55M | 833.24K |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 2.07M | 2.73M | 3.27M | 2.75M |
| Long Term Debt | 2.83M | 2.55M | 2.66M | 2.75M |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 0.00 | 633.64K | 634.14K | 798.09K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 2.83M | 3.18M | 3.29M | 3.55M |
| Total Liabilities | 4.90M | 5.91M | 6.56M | 6.30M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 3.83M | 11.25M | 12.81M | 17.89M |
| Common Par | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Paid In Capital | 68.85M | 66.05M | 54.28M | 43.84M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -65.02M | -54.81M | -41.47M | -25.95M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Capitalization | 6.66M | 13.79M | 15.47M | 20.64M |
| Total Equity | 3.83M | 11.25M | 12.81M | 17.89M |
| Total Liabilities & Stock Equity | 8.73M | 17.16M | 19.38M | 24.19M |
| Total Common Shares Outstanding | 9.63M | 8.03M | 7.49M | 6.24M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 8.03M | 7.85M | 6.63M | 6.23M |
| Diluted Weighted Shares Outstanding | 8.03M | 7.85M | 6.63M | 6.23M |
| Number of Employees | 23 | 34 | 33 | 24 |
| Number of Part-Time Employees | 3 | 2 | 3 | 2 |
Portfolios with APPY
- Portfolio NameUser Type
- UserSUPRATRADE-2709091838
- UserBrahmsian's Debt/Equity Por...
- UserBrahmsian's Financially Sou...
- Userdan vosika Portfolio 1
- Usergame on
- Userdreamerl3oi Portfolio 1
- Useremannn Portfolio 1
- UserKBEE Portfolio 1
- UserMoney and Suits Portfolio 1
- UserFly Me To The Moon Monster ...
Latest APPY Headlines from TheStreet
- Biotech Sector Weekly Rewind 11.13.10 | 07:11 am
- Vantage Drilling, First M&F: Volume Movers 07.20.10 | 07:07 am
- AspenBio Finds Fault Afar for Failure 07.20.10 | 06:07 am
- Biotech Stock Mailbag: Spectrum Pharma 06.18.10 | 07:06 am
- Hellenic Telecom, AspenBio Pharma: Midday Volume Plays 06.07.10 | 12:06 pm
- Stock Offerings: Navios Maritime 04.30.10 | 11:04 am
- Biotech Stock Mailbag: AspenBio 04.30.10 | 06:04 am
- ClickSoftware, AspenBio: Early Volume Plays 12.29.09 | 07:12 am
- AspenBio Pharma Prices Public Offering 10.07.09 | 08:10 am
- Biotech News Roundup: Aspen, AMAG, Vertex 08.17.09 | 12:08 pm
Press Releases for APPY
- AspenBio Appoints Diagnostics Industry Veteran Don Hurd As Senior Vice President And Chief Commercial Officer - Business Wire 05.24.12 | 09:05 am
- AspenBio Pharma’s Clinical Study Suggests One-Third Of CT Scans Used To Assess Pediatric And Adolescent Patients At Low Risk For Acute Appendicitis Could Potentially Be Avoided - Business Wire 04.18.12 | 09:04 am
- Results Of 503-Patient Clinical Study Of AspenBio Pharma’s AppyScore™ Blood Test Show 97% Negative Predictive Value For Absence Of Acute Appendicitis In Children And Adolescents Presenting With Abdominal Pain - Business Wire 03.16.12 | 02:03 pm
- Study Demonstrates AspenBio Pharma’s AppyScore Multi-Marker Blood Test Highly Predictive For Absence Of Acute Appendicitis In Children With Abdominal Pain - Business Wire 02.28.12 | 09:02 am
- Rigrodsky & Long, P.A. Announces Class Action Lawsuit Against AspenBio Pharma, Inc. - Business Wire 10.07.10 | 04:10 pm
- The Law Office Of Robbins Umeda LLP Announces The Filing Of A Class Action Suit Against AspenBio Pharma, Inc. - Business Wire 10.07.10 | 04:10 pm
- Investor Notice: The Rosen Law Firm Announces Investigation Of Shareholder Securities Claims Against AspenBio Pharma, Inc. --- APPY - Business Wire 09.03.10 | 08:09 pm
Partner Headlines for APPY
- Morning Market Losers - Benzinga 12.19.11 | 09:12 am
- AspenBio Pharma Reports AppyScore(TM) ELISA-Based Pivotal Trial Results and Outlines Plans for AppyScore Cassette-Based Test - Benzinga 07.19.10 | 04:07 pm
- AspenBio Pharma Shares Plummet on Drug Application Delay - Fox Business 06.07.10 | 04:06 pm
- 4 Small Cap Biotechs To Keep an Eye On - Seeking Alpha 05.26.10 | 04:05 pm
- Thursday Outlook: What, Me Worry? - Seeking Alpha 05.13.10 | 10:05 am
- Biotech CROs Take Center Stage in Recent Deals - Seeking Alpha 05.02.10 | 05:05 am
- Takeover Speculation Swarms at AspenBio Pharma - SeekingAlpha.com 04.26.10 | 03:04 am
- Preview of AspenBio's Potentially Blockbuster Clinical Trials - SeekingAlpha.com 04.25.10 | 08:04 am
- Friday Options Recap - SeekingAlpha.com 04.23.10 | 03:04 pm
- Will AspenBio Pharma Follow in Dendreon and Human Genome Sciences' Footsteps? - SeekingAlpha.com 04.22.10 | 04:04 am
